News Search Results
Jun 08, 2026, 07:00 ET Protego Biopharma Appoints Jae B. Kim, MD, as Chief Medical Officer
SAN DIEGO, June 8, 2026 /PRNewswire/ -- Protego Biopharma, Inc., a clinical-stage biotechnology company focused on developing small-molecule drugs that target protein misfolding diseases, today announced the appointment of Jae B. Kim, MD, as
More news about: Protego Biopharma
Jun 08, 2026, 05:01 ET Kali Therapeutics Announces Poster Presentation of KT209, a Novel CD19 x CD20 x CD3 Trispecific Antibody, at the EHA 2026 Annual Congress
SAN MATEO, Calif., June 8, 2026 /PRNewswire/ -- Kali Therapeutics, a clinical-stage biotechnology company pioneering next-generation immune-resetting and multi-specific therapies, today announced that preclinical data for KT209, its novel trispecific
More news about: Kali Therapeutics
Jun 08, 2026, 04:09 ET WuXi Biologics Ireland Wins Top Honors at the 2026 Life Sciences Industry Awards
among Ireland's foremost industry recognition programs, celebrating excellence, innovation, and leadership across the country's pharmaceutical, biotechnology, medical device, and broader life sciences sectors. The company was shortlisted across eight award categories, reflecting the breadth of
More news about: WuXi Biologics
Jun 07, 2026, 21:28 ET Dayspring Pharma Announces Positive Topline Results from Phase II Clinical Trial of CG2001 for the Treatment of Androgenetic Alopecia (AGA)
SEOUL, South Korea, June 7, 2026 /PRNewswire/ -- Dayspring Pharma, a clinical-stage biotechnology company focused on innovative dermatology therapies, announced the first public disclosure of positive topline results from its Phase II randomized,
More news about: Dayspring Pharma
Jun 07, 2026, 20:10 ET Ascletis Reinforces Its Differentiated Obesity Portfolio at American Diabetes Association (ADA) 2026 Scientific Sessions, Showcasing ASC30 Clinical Data and Exciting Preclinical Findings from ASC37 and ASC39
clinical development in obesity and metabolic diseases.About Ascletis Pharma Inc.Ascletis Pharma Inc. is a fully integrated biotechnology company focused on the development and commercialization of potential best-in-class and first-in-class therapeutics to treat metabolic diseases.
More news about: Ascletis Pharma Inc.
Jun 07, 2026, 20:08 ET OriCell's GPC3 CAR-T Receives NMPA Clearance for Confirmatory Phase II Trial in Late-Line Advanced Hepatocellular Carcinoma
competing actively in international markets."About OriCell TherapeuticsOriCell Therapeutics is a clinical-stage, globally oriented biotechnology company committed to pioneering cancer immunotherapy. Focused on addressing unmet medical needs in oncology and immunology, the company has built
More news about: Oricell Therapeutics Holdings Limited
Jun 07, 2026, 16:45 ET AMGEN PRESENTS NEW DATA ACROSS ITS CARDIOMETABOLIC PORTFOLIO AT AMERICAN DIABETES ASSOCIATION 86TH SCIENTIFIC SESSIONS
best of biology and technology, Amgen reaches millions of patients with its medicines.More than 45 years ago, Amgen helped establish the biotechnology industry at its U.S. headquarters in Thousand Oaks, California, and it remains at the cutting edge of innovation, using technology and human genetic
More news about: Amgen
Jun 07, 2026, 11:00 ET Lilly's Foundayo (orforglipron), the only oral GLP-1 taken without food or water restrictions, was associated with significant weight loss in women at every stage of menopause
pioneering life-changing discoveries for 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges:
More news about: Eli Lilly and Company
Jun 06, 2026, 14:30 ET Lilly's triple agonist, retatrutide, drove substantial improvements in weight, A1C, knee osteoarthritis pain, and obstructive sleep apnea, demonstrating its remarkable potential to treat obesity and its complications
pioneering life-changing discoveries for 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges:
More news about: Eli Lilly and Company
Jun 06, 2026, 11:08 ET MONDAY INVESTOR DEADLINE: Medpace Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces - MEDP
Medpace is a clinical contract research organization (CRO) focused on providing scientifically-driven outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries.The Medpace class action lawsuit alleges that defendants throughout the
More news about: Robbins Geller Rudman & Dowd LLP
Jun 05, 2026, 20:30 ET Ractigen Therapeutics Announces ADA 2026 Late-Breaking Presentation Highlighting saRNA as a New Frontier in Obesity Control
NEW ORLEANS, June 5, 2026 /PRNewswire/ -- Ractigen Therapeutics, a pioneering clinical-stage biotechnology company developing innovative small activating RNA (saRNA) therapeutics, today announced that a late-breaking abstract on LiCO-saUcp1, its first-in-class
More news about: Ractigen Therapeutics
Jun 05, 2026, 19:30 ET Bio Preventive Medicine and Precision Diabetes Announce ADA Late-Breaking Presentation Highlighting DNlite™ in Landmark CREDENCE Trial
contributions and collaboration on this work.About Bio Preventive Medicine Corp.Bio Preventive Medicine Corp. is a clinical-stage biotechnology company focused on advancing precision diagnostics for kidney disease and chronic metabolic disorders. The company develops biomarker-driven solutions
More news about: Precision Diabetes, Inc.
Jun 05, 2026, 17:01 ET Food Safety Testing Market Expected to Reach $44.1 Billion by 2033, at a CAGR of 7% : Allied Market Research
diagnostics to detect pathogens and GMOs. As PCR technology is broadly implemented across the entire product development stage in agricultural biotechnology, Allied Market Research identifies it as a key player in the food safety testing technology space. New techniques for rapid pathogen testing such
More news about: Allied Market Research
Jun 05, 2026, 15:15 ET SynbioTech Launches SYNMUE™ Targeting Immunosenescence, to Showcase at Probiota Americas 2026 in Vancouver
VANCOUVER, BC, June 5, 2026 /PRNewswire/ -- Synbio Tech Inc. (SynbioTech), a global leader in biotechnology solutions, today announced the launch of SYNMUE™, a clinically validated probiotic featuring Lactiplantibacillus plantarum LP28, designed
More news about: SYNBIO TECH INC.
Jun 05, 2026, 09:00 ET VetrixBio Announces Positive Clinical Data for VTX-304, a First-in-Class Bispecific Antibody for Canine Osteoarthritis
degeneration in one molecule, VTX-304 aims to provide meaningful disease-modifying benefits.About VetrixBio VetrixBio, Inc. is a biotechnology company focused on developing novel biologic therapies for companion animals. Guided by the belief that pets deserve better medicine, the company
More news about: VetrixBio, Inc.
Jun 05, 2026, 09:00 ET Diakonos Oncology Shares Updated DOC1021 GBM Survival Data and Unveils Melanoma Clinical Study at ASCO 2026
Diakonos Oncology Corp., a clinical-stage biotechnology company developing a new generation of immunotherapies to treat challenging and aggressive cancers, today announced the presentation of two posters
More news about: Diakonos Oncology
Jun 05, 2026, 01:59 ET Aphranel® Marks First Anniversary with EU MDR Certification, Arc™ Launch, and Over 150,000 Syringes Delivered
with BSI, a UK-based Notified Body and one of the world's first MDR-designated organizations.Over the past 12 years, Shanghai Moyom, the biotechnology company behind Aphranel, has remained committed to long-term biomaterial research and regenerative CaHA technology, driving advances in microsphere
More news about: Aphranel
Jun 05, 2026, 01:20 ET Aphranel® Marks First Anniversary with EU MDR Certification, Arc™ Launch, and Over 150,000 Syringes Delivered
with BSI, a UK-based Notified Body and one of the world's first MDR-designated organizations.Over the past 12 years, Shanghai Moyom, the biotechnology company behind Aphranel, has remained committed to long-term biomaterial research and regenerative CaHA technology, driving advances in microsphere
More news about: Aphranel
Jun 04, 2026, 16:39 ET Lupin Receives Approval from U.S. FDA for Ranluspec™(ranibizumab) Injection
reinforces our commitment to expanding access to advanced, affordable therapies for patients worldwide," said Dr. Cyrus Karkaria, President Biotechnology, Lupin.About Lupin Lupin Limited is a global pharmaceutical leader headquartered in Mumbai, India, with products distributed
More news about: Lupin Pharmaceutical, Inc.
Jun 04, 2026, 16:20 ET Pacira BioSciences Reminds Stockholders to Vote the BLUE Proxy Card "FOR" the Election of the Company's Highly Qualified Nominees Ahead of its Annual Meeting
interests of all stockholders. Not only does DOMA's campaign reflect a fundamental misunderstanding of Pacira's strategy, business and the biotechnology industry, but DOMA has also failed to articulate a credible plan to drive sustainable stockholder value. DOMA is attempting to replace members of
More news about: Pacira BioSciences, Inc.
Jun 04, 2026, 16:01 ET AMGEN TO PRESENT AT THE GOLDMAN SACHS 47TH ANNUAL GLOBAL HEALTHCARE CONFERENCE
best of biology and technology, Amgen reaches millions of patients with its medicines.More than 45 years ago, Amgen helped establish the biotechnology industry at its U.S. headquarters in Thousand Oaks, California, and it remains at the cutting edge of innovation, using technology and human genetic
More news about: Amgen
Jun 04, 2026, 13:06 ET Rubin Rudman Opens Westborough, MA Office
Rubin Rudman serves national and international companies, including large public companies and closely held businesses; real estate developers; biotechnology, pharmaceutical and medical device makers; hospitality companies; regulated industries, public entities and municipalities; insurance companies
More news about: Rubin Rudman
Jun 04, 2026, 11:21 ET Mesenchymal Stem Cells Market Forecast 2031: 12%+ CAGR, Growing Clinical Research & Regenerative Medicine Applications to Drive Market Expansion, Says Mordor Intelligence
initiatives, and increasing collaboration among academic institutions, biotechnology companies, and healthcare providers. Asia-Pacific is emerging as a high-growth region due to rising healthcare investments, expanding biotechnology capabilities, growing regenerative medicine research activities,
More news about: Mordor Intelligence Private Limited
Jun 04, 2026, 10:30 ET Made Scientific and Pluristyx Launch Integrated iPSC Development & Manufacturing Partnership to Advance Next-Generation iPSC-derived Cell Therapies
deliver reliable and scalable solutions, supported by their long-term strategic backer, GC Corporation, a global leader in the pharmaceutical and biotechnology sectors. For more information, visit
More news about: Made Scientific, Inc.
Jun 04, 2026, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Regencell Bioscience Holdings Limited and Certain Officers - RGC
$14 billion. As The Wall Street Journal observed in January 2026, "[f]or context, only 20 of the 261 companies in the Nasdaq Biotechnology Index had a greater market value; the index doesn't include Regencell." At all relevant times, Defendants downplayed the likelihood and severity
More news about: Pomerantz LLP